Rapid Micro Biosystems, Inc. (RPID) stock
Close on Nov 11, 2026Market cap $37.47MP/E –Yield –
Rapid Micro Biosystems, Inc. grew revenue 16.1% to $35.18M over the twelve months to Jun 30, 2026. Free cash flow was -$40.39M. At the latest close the market valued the company at $37.47M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $37.47M
- P/E ratio
- –
- Price to sales
- 1.07
- Price to book
- 2.11
- Dividend yield
- –
- Free cash flow yield
- -107.79%
Fundamentals
- Revenue
- $35.18M
- Net income
- -$51.20M
- EPS, diluted
- -$1.12
- Free cash flow
- -$40.39M
- Book value per share
- $0.37
- Diluted shares
- 48M
Trading
- Next earnings
- Q3 FY2026, expected soon
- Previous close
- $0.75
- Open
- $0.77
- Day's range
- $0.74 – $0.79
- Volume
- 175,558
- Average volume (20 days)
- 168,235
- Beta (5 years)
- 1.46
- 52-week range
- $0.58 – $4.94
- RSI (14 days)
- 41.5
- Volatility (1 year)
- 81.0%
- Relative volume
- 0.72×
- WACC
- 11.3%
Market cap history
Month-end market cap since 2021, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | RPID | S&P 500 | Difference | RPID per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -16.4% | -2.4% | −14.0 pts | ||
| 3 months | -55.8% | -1.2% | −54.6 pts | ||
| Year to date | -74.2% | +12.3% | −86.5 pts | ||
| 1 year | -80.1% | +12.4% | −92.6 pts | ||
| 3 years | -23.1% | +78.8% | −101.9 pts | -8.4% | +21.4% |
| 5 years | -96.5% | +75.2% | −171.7 pts | -48.9% | +11.9% |
Seven years at a glance
Fiscal years 2019 to 2025 and trailing twelve months, USD
Revenue
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Rapid Micro Biosystems filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
About Rapid Micro Biosystems
Laboratory Analytical Instruments
The company develops and commercializes automated microbial quality control solutions for pharmaceutical and biopharmaceutical manufacturing. Its core offering is the Growth Direct platform, an automated system that detects and enumerates microbial contamination in manufacturing environments, water systems, raw materials, and finished sterile products. The platform integrates robotic handling, optical imaging, and vision algorithms to replace manual growth-based testing methods. The company also supplies proprietary consumable plates designed for specific testing applications, laboratory information management system connectivity software, and consultative validation and maintenance services. Its customers include global pharmaceutical companies and manufacturers of advanced therapeutics such as biologics, vaccines, sterile injectables, and cell and gene therapies.
Company profile, executives and historyRapid Micro Biosystems stock: common questions
What is Rapid Micro Biosystems's stock price?
RPID closed at $0.75 on Nov 11, 2026, down 0.84% on the day. Over the past 52 weeks it traded between $0.58 and $4.94.
What is Rapid Micro Biosystems's market cap?
Rapid Micro Biosystems was worth $37.47M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is RPID's P/E ratio?
Rapid Micro Biosystems lost money over the twelve months to Jun 30, 2026 (diluted EPS -$1.12), so it has no meaningful P/E ratio.
How much revenue does Rapid Micro Biosystems make?
Rapid Micro Biosystems reported revenue of $35.18M for the twelve months to Jun 30, 2026, up 16.1% from a year earlier.
Does Rapid Micro Biosystems pay a dividend?
No. Rapid Micro Biosystems has not paid a cash dividend over the last twelve months.
When does Rapid Micro Biosystems report earnings next?
Rapid Micro Biosystems's Q3 FY2026 results are due soon; the company has not yet filed them with the SEC.
How has RPID stock performed over the past year?
Including dividends, RPID returned -80.1% over the past year, against +12.4% for the S&P 500.
How many RPID shares are sold short?
1M shares were sold short at the latest FINRA report, 2.93% of the float, or 5.5 days of average trading volume.
Who are Rapid Micro Biosystems's competitors?
Companies most similar to Rapid Micro Biosystems by business, industry and size include BNGO, SEER, HBIO, PRPO, MASS.
See a number that looks wrong?